Skip to main content
. 2011 Jun 1;84(6):847–850. doi: 10.4269/ajtmh.2011.10-0693

Table 1.

Summary of patient demographics and clinical presentation*

Patient number Sex Age Birth country Number of lesions; lesion location Diagnosis Duration of disease Treatment course
1 M 28 Somalia 1, right thumb CL (L. panamensis) 5 weeks First: LAmB (Days 1–7, 10, 14) Second: LAmB (Days 1–14, 17, 21)
2 M 22 Somalia 1, right pinna CL (L. panamensis) 5 weeks LAmB (Days 1–7, 10, 14)
3 M 21 Somalia 1, left lateral foot CL (L. panamensis) 4 weeks First: LAmB (Days 1–7, 10, 14) Second: LAmB (Days 1–14, 17, 21)
4 M 26 Ethiopia 1, right posterior calf CL (L. panamensis) 8 weeks LAmB (Days 1–7, 10, 14)
5 M 24 Somalia 3, medial thigh-bilaterally CL (L. panamensis) No report LAmB (Days 1–7, 10, 14)
*

Description of individual patient demographics (M = male); lesion location, number, and duration; diagnosis (CL = cutaneous leishmaniasis); treatment course(s) (LAmB = liposomal amphotericin B).

Patient 5 refused to disclose any information about his journey.